Skip to main content

Want a detailed portfolio tracker?

BioAffinity Technologies (BIAF) P/E (2022 - 2026)

BioAffinity Technologies (BIAF) P/E from Sep 30, 2022 to Jun 2, 2026. The TTM BioAffinity Technologies (BIAF) P/E is -0.23. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of BioAffinity Technologies (BIAF)

YearP/EChange
2026-0.23+112.49%
2025-0.11-91.62%
2024-1.30-26.26%
2023-1.77-35.06%
2022-2.72N/A

Comparison BioAffinity Technologies (BIAF) P/E with competitors

BioAffinity Technologies (BIAF) P/E is -0.23.

TickerNameP/EUpside
ADVBAdvanced Biomed Inc0.78-436.15%
MBAICheckCap Ltd2.88-1343.35%
FONRFonar Corp15.41-6747.71%
QGENQiagen NV17.55-7668.36%
IQVIQVIA Holdings Inc20.25-8833.86%
DGXQuest Diagnostics Inc21.62-9424.70%
LHLaboratory Corp Of America Holdings22.66-9874.33%
AAgilent Technologies Inc25.45-11076.23%
MEDPMedpace Holdings Inc26.32-11453.40%
TMOThermo Fisher Scientific Inc26.87-11689.41%
MTDMettler-Toledo International Inc26.96-11728.23%
DHRDanaher Corp33.26-14443.56%
ILMNIllumina Inc34.97-15183.88%
ICLRIcon Plc39.55-17156.09%
IDXXIdexx Laboratories Inc40.14-17410.51%
VCYTVeracyte Inc40.15-17418.79%
RVTYRevvity Inc45.79-19850.16%
SHCSotera Health Company63.43-27457.51%
WATWaters Corp93.81-40559.96%